Javascript must be enabled to continue!
Cost‐Effectiveness Analysis of Hepatitis E Vaccination Strategies for Swine Workers
View through CrossRef
Hepatitis E virus (HEV) is endemic in China, with swine as the most common reservoir. It poses a zoonotic public health risk to swine workers. This study evaluated the cost‐effectiveness of hepatitis E vaccination for this high‐risk group in China. A decision tree‐Markov model was utilized to evaluate the cost‐effectiveness of two hepatitis E vaccination strategies, without or following screening, for swine workers aged 16–60 in China from societal perspectives, compared to no vaccination. We calculated HEV‐related cases and deaths averted, quality‐adjusted life years (QALYs) gained, and incremental cost‐effectiveness ratios (ICERs) with a willingness‐to‐pay (WTP) threshold of GDP per capita. A sensitivity analysis was conducted. Additionally, we stimulated the scenarios of fully receiving 3‐dose schedule, partially receiving 3‐dose schedule, and fully receiving 2‐dose schedule. Both hepatitis E vaccination strategies significantly reduced HEV‐related cases and deaths compared to no vaccination. ICERs were estimated to be USD 11,428.16 and 9830.71/QALY averted for vaccination without and following screening, respectively, both lower than GDP per capita (USD 12,325.24, 2023). Furthermore, one‐way sensitivity analysis identified the discount rate, utility in asymptomatic cases, and probability of symptomatic infection as crucial factors affecting ICER. Probabilistic sensitivity analysis (PSA) showed a 47.5% cost‐effectiveness probability for hepatitis E vaccination following screening, compared to 52.5% for no vaccination. Notably, vaccination following screening was cost‐ineffective after age 40 and at a price of USD 138.0/dose. Additionally, fully receiving 2‐dose and partially 3‐dose schedules were cost‐effective, regardless of hepatitis E vaccination without or following screening strategies, while fully receiving 3‐dose schedule was cost‐ineffective with the vaccination without screening strategy. Hepatitis E vaccination following screening would be optimal for swine workers in China. Vaccination starting at an earlier age and lower vaccine prices can improve the cost‐effectiveness. Additionally, 2‐dose schedule may be recommended during a hepatitis E outbreak to achieve cost‐effectiveness.
Title: Cost‐Effectiveness Analysis of Hepatitis E Vaccination Strategies for Swine Workers
Description:
Hepatitis E virus (HEV) is endemic in China, with swine as the most common reservoir.
It poses a zoonotic public health risk to swine workers.
This study evaluated the cost‐effectiveness of hepatitis E vaccination for this high‐risk group in China.
A decision tree‐Markov model was utilized to evaluate the cost‐effectiveness of two hepatitis E vaccination strategies, without or following screening, for swine workers aged 16–60 in China from societal perspectives, compared to no vaccination.
We calculated HEV‐related cases and deaths averted, quality‐adjusted life years (QALYs) gained, and incremental cost‐effectiveness ratios (ICERs) with a willingness‐to‐pay (WTP) threshold of GDP per capita.
A sensitivity analysis was conducted.
Additionally, we stimulated the scenarios of fully receiving 3‐dose schedule, partially receiving 3‐dose schedule, and fully receiving 2‐dose schedule.
Both hepatitis E vaccination strategies significantly reduced HEV‐related cases and deaths compared to no vaccination.
ICERs were estimated to be USD 11,428.
16 and 9830.
71/QALY averted for vaccination without and following screening, respectively, both lower than GDP per capita (USD 12,325.
24, 2023).
Furthermore, one‐way sensitivity analysis identified the discount rate, utility in asymptomatic cases, and probability of symptomatic infection as crucial factors affecting ICER.
Probabilistic sensitivity analysis (PSA) showed a 47.
5% cost‐effectiveness probability for hepatitis E vaccination following screening, compared to 52.
5% for no vaccination.
Notably, vaccination following screening was cost‐ineffective after age 40 and at a price of USD 138.
0/dose.
Additionally, fully receiving 2‐dose and partially 3‐dose schedules were cost‐effective, regardless of hepatitis E vaccination without or following screening strategies, while fully receiving 3‐dose schedule was cost‐ineffective with the vaccination without screening strategy.
Hepatitis E vaccination following screening would be optimal for swine workers in China.
Vaccination starting at an earlier age and lower vaccine prices can improve the cost‐effectiveness.
Additionally, 2‐dose schedule may be recommended during a hepatitis E outbreak to achieve cost‐effectiveness.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Knowledge and practices related to swine flu in school students of Bhavnagar, Gujarat
Knowledge and practices related to swine flu in school students of Bhavnagar, Gujarat
Context: Swine Flu caused by Influenza virus of H1N1 strain is a highly infectious respiratory disease. Knowledge and awareness among the community regarding the containment of spr...
Cost-Utility Analysis of Expanding Hepatitis B Vaccination Among Healthcare Workforce in Ethiopia
Cost-Utility Analysis of Expanding Hepatitis B Vaccination Among Healthcare Workforce in Ethiopia
Abstract
Objective Ethiopia is one of the countries with high endemicity of hepatitis B infection. In Ethiopia, the current vaccine coverage among health care workers accou...
P1333 Patients with Inflammatory Bowel Disease exhibit poor response to Hepatitis B vaccination but maintain protective Measles antibody titres
P1333 Patients with Inflammatory Bowel Disease exhibit poor response to Hepatitis B vaccination but maintain protective Measles antibody titres
Abstract
Background
Patients with inflammatory bowel disease (IBD) are prone to infections due to disease activity, malnu...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Cost-Utility Analysis of Expanding Hepatitis B Vaccination among Healthcare Workforce in Ethiopia
Cost-Utility Analysis of Expanding Hepatitis B Vaccination among Healthcare Workforce in Ethiopia
Abstract
Objective: Three doses of monovalent Hepatitis B vaccinations that given for six months were the most effective as well as a safe way to prevent Hepatitis B viral ...
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
SummaryResearch in contextEvidence before this studyWe first searched PubMed for articles published until November 2023 with the keywords “(“HPV”) AND (“Vaccine” or “Vaccination”) ...

